Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Academic Article 2009 uri icon

authors

  • Negredo E
  • Domingo P
  • Alonso-Villaverde C
  • Bonjoch A
  • Morén C
  • Pérez-Alvarez N
  • Clotet B
  • MULTINEKA Study Group (Gutiérrez F among others)
  • GUTIERREZ RODERO, FELIX
  • Miró O
  • Rodriguez B
  • Garrabou G
  • Estany C
  • Masabeu A
  • Force L
  • Barrufet P
  • Cucurull J

publication date

  • 2009